While it's declined in states with adult-use mkts, US medical cannabiz is currently still "at least a $10 billion market," Tilray ceo Irwin Simon noted on the co's earnings call last wk. And "recent developments in the US have strengthened our optimism around rescheduling of medical cannabis," as it's "seen...
Read more...
Tilray Optimism for Medical Rescheduling in US "Strengthened"; $300-500 Biz Oppy; D-9 Progress; Bitcoin Buy
Publishing Info
- Year: 2025
- Volume: 27
- Issue #: 215
- Issue Date: 10/13/2025
Newsletter
INSIGHTS Express